"At UCSF Health, we're taking every precaution to keep you safe and healthy during the COVID-19 pandemic. For our outpatients, we offer video visits and virtual care for hundreds of conditions as well as for primary care, mental health services, medication monitoring and more. In our hospitals, we test every patient admitted and before most procedures. Our staff wears face masks and practices rigorous hand hygiene, as well as many other methods of infection prevention. Before entering your room, they'll make sure you're masked and (in UCSF Benioff Children's Hospitals) that your child age 2+ is masked. If you're planning to visit someone in the hospital, be sure to check our COVID-19 visitor restrictions before going."

During the past decade, UCSF Center for Reproductive Health conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSF Center for Reproductive Health" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCSF Center for Reproductive Health" are "Infertility" (3 trials), "Insulin Resistance" (2 trials), "Asherman's Syndrome" (1 trials), "Depression" (1 trials) and "Diminished Ovarian Reserve" (1 trials). Many other conditions were trialed in "UCSF Center for Reproductive Health" in a lesser frequency.

Most popular intervention types in "UCSF Center for Reproductive Health" are "Drug" (3 trials), "Behavioral" (1 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ganirelix acetate" (1 trials), "INVOcell device" (1 trials), "Intrauterine infusion of platelet rich plasma" (1 trials), "Letrozole" (1 trials) and "Metformin" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCSF Center for Reproductive Health" are 7 trials for "Female" genders.

Currently, there are NaN active trials in "UCSF Center for Reproductive Health". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UCSF Center for Reproductive Health, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in UCSF Center for Reproductive Health, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".